(SPAC) Special Purpose Acquisition Investigation: ADN, TNGX, SNTI, OPFI, Contact Shareholder Rights Law Firm Johnson Fistel


SAN DIEGO, Feb. 21, 2023 (GLOBE NEWSWIRE) -- Shareholder rights law firm Johnson Fistel, LLP is investigating potential violations of law in connection with the following special purpose acquisition companies ("SPACs"): Advent Technologies Holdings, Inc. f/k/a AMCI Acquisition Corp (NASDAQ: ADN), Tango Therapeutics, Inc. f/k/a BCTG Acquisition Corp (NASDAQ: TNGX), Senti Biosciences Inc. f/k/a Dynamics Special Purpose Corp (NASDAQ: SNTI), and OppFi Inc. f/k/a FG New America Acquisition Corp (NYSE: OPFI).

If you are an investor purchasing any of the SPACs below and suffered losses: Click or paste the following web address into your browser to submit your information:

Advent Technologies Holdings, Inc. f/k/a AMCI Acquisition Corp (NASDAQ: ADN): https://www.cognitoforms.com/JohnsonFistel/AdventTechnologiesHoldingsIncFkaAMCIAcquisitionCorp

Tango Therapeutics, Inc. f/k/a BCTG Acquisition Corp (NASDAQ: TNGX): https://www.cognitoforms.com/JohnsonFistel/TangoTherapeuticsIncFkaBCTGAcquisitionCorp

Senti Biosciences Inc. f/k/a Dynamics Special Purpose Corp (NASDAQ: SNTI): https://www.cognitoforms.com/JohnsonFistel/SentiBiosciencesIncFkaDynamicsSpecialPurposeCorp

OppFi Inc. f/k/a FG New America Acquisition Corp (NYSE: OPFI): https://www.cognitoforms.com/JohnsonFistel/OppFiIncFkaFGNewAmericaAcquisitionCorp

Or for more information, contact Jim Baker at jimb@johnsonfistel.com or (619) 814-4471

About Johnson Fistel, LLP:
Johnson Fistel, LLP is a nationally recognized shareholder rights law firm with offices in California, New York and Georgia. The firm represents individual and institutional investors in shareholder derivative and securities class action lawsuits. Johnson Fistel seeks to recover losses incurred due to violations of federal securities laws. For more information about the firm and its attorneys, please visit http://www.johnsonfistel.com. Attorney advertising. Past results do not guarantee future outcomes.

Contact:
Johnson Fistel, LLP
Jim Baker, 619-814-4471
Investor Relations
jimb@johnsonfistel.com